Sohonos 1 mg (Palovarotene CAPSULE) 1 MG

SOHONOS 1 MG capsules contain palovarotene, a medication used for managing conditions related to excessive bone growth. This oral treatment is designed to help control symptoms and improve quality of life.

Strength

1 MG

Manufacturer / TM Owner

IPSEN BIOPHARMACEUTICALS CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

SOHONOS 1 MG capsules are primarily used to manage conditions characterized by abnormal bone growth. Palovarotene, the active ingredient, works by modulating certain cellular processes to help control these symptoms. This medication is often considered for conditions where excessive bone formation can lead to complications.

Side Effects

Common effects of SOHONOS 1 MG capsules may include mild gastrointestinal discomfort, such as nausea or stomach upset. Some users might also experience fatigue or dizziness. These effects are generally temporary and may vary from person to person.

Precautions & Warnings

SOHONOS 1 MG capsules should be handled with care, following the guidelines provided by a healthcare professional. It is important to store the medication in a cool, dry place away from direct sunlight. Always consult a healthcare provider before starting any new medication.

Avoid Interactions

SOHONOS 1 MG capsules may interact with certain medications, including those that affect liver enzymes. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare professional.

Frequently Asked Questions

SOHONOS 1 MG capsules are used to manage conditions related to excessive bone growth, helping to control symptoms and improve quality of life.

SOHONOS 1 MG capsules are taken orally, typically as directed by a healthcare professional. Always follow the prescribed dosage and administration instructions.

Common side effects may include mild gastrointestinal discomfort, fatigue, and dizziness. These effects are usually temporary and may vary among individuals.

It is advisable to consult your healthcare provider about alcohol consumption while taking SOHONOS 1 MG capsules to avoid potential interactions.

SOHONOS 1 MG capsules should be stored in a cool, dry place away from direct sunlight and out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.